Despite a Newly Approved Treatment, The Cystic Fibrosis Foundation Isn’t Slowing Down its Efforts
Free-Photos / Pixabay

Despite a Newly Approved Treatment, The Cystic Fibrosis Foundation Isn’t Slowing Down its Efforts

According to a story from statnews.com, the approval of the new cystic fibrosis drug Trikafta has caused quite a buzz in this rare disease community. While this new drug offers…

Continue Reading Despite a Newly Approved Treatment, The Cystic Fibrosis Foundation Isn’t Slowing Down its Efforts
A Team of Scientists are Working on a Researching Treatments for Ulcerative Colitis
luvqs / Pixabay

A Team of Scientists are Working on a Researching Treatments for Ulcerative Colitis

According to a story from Medical Xpress, an international team of scientist from 34 different countries are putting their heads together to identify the most effective treatments for ulcerative colitis,…

Continue Reading A Team of Scientists are Working on a Researching Treatments for Ulcerative Colitis
Doctors Call for Screening of Juvenile Idiopathic Arthritis Patients to Identify Rare Lung Disease
nastya_gepp / Pixabay

Doctors Call for Screening of Juvenile Idiopathic Arthritis Patients to Identify Rare Lung Disease

According to a story from newswise.com, biologic medicines have had a major positive impact on outcomes for patients with the rare disease juvenile idiopathic arthritis (JIA). However, as these medicines…

Continue Reading Doctors Call for Screening of Juvenile Idiopathic Arthritis Patients to Identify Rare Lung Disease
Two Best Friends With Primary Immunodeficiency Meet for the First Time in Cape Town, South Africa
Olichel / Pixabay

Two Best Friends With Primary Immunodeficiency Meet for the First Time in Cape Town, South Africa

According to a story from Cape Town Etc, two girls in South Africa were living with the same rare disease: primary immunodeficiency (PI), a group of rare conditions in which…

Continue Reading Two Best Friends With Primary Immunodeficiency Meet for the First Time in Cape Town, South Africa
Marketing Applications for a Possible Neuromyelitis Optica Spectrum Disorder Drug Have Been Accepted in the US and EU
LhcCoutinho / Pixabay

Marketing Applications for a Possible Neuromyelitis Optica Spectrum Disorder Drug Have Been Accepted in the US and EU

According to a story from BioSpace, Chugai Pharmaceutical Co., Ltd. has recently announced that the Marketing Authorisation Application for the its drug satralizumab has been accepted by the European Medicines…

Continue Reading Marketing Applications for a Possible Neuromyelitis Optica Spectrum Disorder Drug Have Been Accepted in the US and EU